Hvsen Biotechnology Co., Ltd.
SZSE:300871.SZ
14.16 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 227.161 | 204.501 | 328.373 | 242.304 | 218.67 | 230.412 | 351.422 | 274.46 | 191.353 | 205.666 | 250.307 | 210.17 | 222.239 | 313.5 | 281.082 | 209.553 | 151.821 | 135.002 | 158.867 | 86.962 |
| Cost of Revenue
| 204.352 | 159.934 | 261.74 | 195.988 | 174.036 | 174.702 | 263.412 | 213.392 | 156.554 | 164.18 | 211.772 | 155.857 | 148.369 | 209.497 | 180.089 | 132.489 | 94.152 | 82.858 | 96.74 | 56.494 |
| Gross Profit
| 22.809 | 44.567 | 66.633 | 46.316 | 44.634 | 55.71 | 88.01 | 61.068 | 34.799 | 41.486 | 38.535 | 54.313 | 73.87 | 104.003 | 100.993 | 77.063 | 57.67 | 52.144 | 62.127 | 30.469 |
| Gross Profit Ratio
| 0.1 | 0.218 | 0.203 | 0.191 | 0.204 | 0.242 | 0.25 | 0.223 | 0.182 | 0.202 | 0.154 | 0.258 | 0.332 | 0.332 | 0.359 | 0.368 | 0.38 | 0.386 | 0.391 | 0.35 |
| Reseach & Development Expenses
| 9.773 | 14.535 | 13.391 | 11.966 | 9.954 | 9.286 | 14.249 | 8.209 | 7.926 | 9.754 | 18.769 | 12.98 | 9.224 | 5.915 | 12.61 | 6.579 | 5.548 | 3.645 | 5.783 | 4.793 |
| General & Administrative Expenses
| -13.379 | 18.413 | -41.51 | 46.039 | -10.509 | 16.525 | -29.795 | 35.255 | -7.93 | 13.562 | -13.002 | 20.594 | 1.891 | 7.845 | -9.025 | 9.793 | -1.125 | 5.284 | -42.165 | 5.323 |
| Selling & Marketing Expenses
| 14.659 | 14.342 | 14.766 | 14.581 | 13.222 | 13.059 | 15.4 | 11.658 | 9.18 | 12.19 | 2.848 | 13.069 | 15.627 | 15.61 | 18.893 | 12.097 | 11.34 | 10.226 | 10.933 | 8.22 |
| SG&A
| 20.584 | 28.581 | -26.745 | 60.621 | 2.712 | 29.584 | -14.395 | 46.913 | 1.249 | 25.752 | -10.154 | 33.662 | 17.518 | 23.455 | 9.868 | 21.89 | 10.215 | 15.51 | -31.232 | 13.543 |
| Other Expenses
| -1.06 | -2.037 | -0.293 | -0.095 | -2.266 | 0.012 | -0.474 | -0.012 | 0.045 | -2.005 | 0.16 | -0.049 | -0.165 | -0.142 | -0.416 | 0.024 | -0.002 | -0.09 | 2.998 | 0.002 |
| Operating Expenses
| 31.417 | 45.152 | 47.314 | 45.332 | 42.05 | 36.663 | 44.396 | 35.012 | 30.603 | 36.027 | 32.064 | 35.497 | 35.705 | 31.264 | 41.491 | 23.304 | 25.024 | 20.03 | 21.567 | 18.473 |
| Operating Income
| -8.608 | -0.585 | -1.906 | -2.628 | 2.997 | 16.619 | 28.723 | 20.068 | 5.566 | 4.799 | 12.905 | 19.925 | 44.566 | 73.632 | 63.052 | 52.468 | 31.499 | 29.498 | 38.076 | 10.508 |
| Operating Income Ratio
| -0.038 | -0.003 | -0.006 | -0.011 | 0.014 | 0.072 | 0.082 | 0.073 | 0.029 | 0.023 | 0.052 | 0.095 | 0.201 | 0.235 | 0.224 | 0.25 | 0.207 | 0.219 | 0.24 | 0.121 |
| Total Other Income Expenses Net
| -34.532 | -20.961 | -0.293 | -0.095 | -2.266 | 0.012 | -0.474 | -0.012 | 0.045 | -2.005 | 0.16 | -0.049 | -0.165 | -0.142 | -0.416 | 0.024 | -0.002 | -0.09 | -0.021 | 0.002 |
| Income Before Tax
| -43.14 | -21.546 | -2.199 | -2.723 | 0.732 | 16.631 | 28.249 | 20.056 | 5.611 | 2.794 | 13.065 | 19.876 | 44.402 | 73.489 | 62.636 | 52.492 | 31.497 | 29.408 | 38.055 | 10.509 |
| Income Before Tax Ratio
| -0.19 | -0.105 | -0.007 | -0.011 | 0.003 | 0.072 | 0.08 | 0.073 | 0.029 | 0.014 | 0.052 | 0.095 | 0.2 | 0.234 | 0.223 | 0.25 | 0.207 | 0.218 | 0.24 | 0.121 |
| Income Tax Expense
| -7.667 | -5.14 | -4.103 | -1.702 | -0.31 | 1.776 | 1.949 | 0.162 | 1.122 | 0.77 | -0.071 | 1.475 | 6.531 | 10.032 | 9.423 | 8.113 | 4.255 | 4.084 | 4.906 | 1.189 |
| Net Income
| -35.473 | -16.406 | 1.903 | -1.021 | 1.042 | 14.856 | 26.3 | 19.893 | 4.489 | 2.024 | 13.137 | 18.401 | 37.871 | 63.457 | 53.212 | 44.379 | 27.242 | 25.324 | 33.149 | 9.32 |
| Net Income Ratio
| -0.156 | -0.08 | 0.006 | -0.004 | 0.005 | 0.064 | 0.075 | 0.072 | 0.023 | 0.01 | 0.052 | 0.088 | 0.17 | 0.202 | 0.189 | 0.212 | 0.179 | 0.188 | 0.209 | 0.107 |
| EPS
| -0.22 | -0.099 | 0.012 | -0.006 | 0.006 | 0.091 | 0.16 | 0.12 | 0.027 | 0.01 | 0.079 | 0.11 | 0.23 | 0.38 | 0.26 | 0.32 | 0.11 | 0.21 | 0.27 | 0.073 |
| EPS Diluted
| -0.22 | -0.099 | 0.012 | -0.006 | 0.006 | 0.091 | 0.16 | 0.12 | 0.027 | 0.01 | 0.079 | 0.11 | 0.23 | 0.38 | 0.26 | 0.32 | 0.11 | 0.21 | 0.27 | 0.073 |
| EBITDA
| 19.078 | 4.82 | 26.874 | 5.418 | 3.395 | 20.523 | 46.797 | 23.977 | 9.083 | 6.847 | 8.003 | 21.015 | 40.881 | 76.207 | 63.302 | 55.646 | 32.928 | 32.052 | 43.92 | 12.307 |
| EBITDA Ratio
| 0.084 | 0.024 | 0.082 | 0.022 | 0.016 | 0.089 | 0.133 | 0.087 | 0.047 | 0.033 | 0.032 | 0.1 | 0.184 | 0.243 | 0.225 | 0.266 | 0.217 | 0.237 | 0.276 | 0.142 |